751 The safety and efficacy of viramidine® plus pegylated interferon alpha-2B versus ribavirin plus pegylated interferon alpha-2B in therapy-naïve patients infected with HCV: Phase 3 results

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Hepatology

• Publication date

  2006-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(06)80739-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Drugs in Development for Hepatitis B

  2017cites this paper
• Current prodrug strategies for improving oral absorption of nucleoside analogues

  2014cites this paper
• Update of old and emerging therapies in chronic hepatitis C.

  2011cites this paper
• New Horizons: IL28, Direct‐Acting Antiviral Therapy for HCV

  2011cites this paper
• Current Therapies for Chronic Hepatitis C

  2011cites this paper
• Ribavirin plus interferon versus interferon for chronic hepatitis C.

  2010cites this paper
• New and experimental therapies for HCV

  2009cites this paper
• A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment‐naïve patients with chronic hepatitis C: ViSER1 results

  2009cites this paper
• Anti-HCV Agents in Development

  2009cites this paper
• Novel drugs for hepatitis C virus

  2009cites this paper
• Taribavirin: a potential alternative to ribavirin

  2009cites this paper
• What future for ribavirin?

  2009cites this paper
• The Utility of Therapeutic Drug Monitoring for Ribavirin in Patients with Chronic Hepatitis C—A Critical Review

  2009cites this paper
• Sequential antiviral and iron chelation treatment in a teenage boy with congenital anemia, chronic hepatitis C, and secondary hemosiderosis.

  2009cites this paper
• Ribavirin monotherapy for chronic hepatitis C.

  2009cites this paper
• Taribavirin for the treatment of chronic hepatitis C

  2008cites this paper
• Pegylated Interferons: Clinical Applications in the Management of Hepatitis C Infection

  2008cites this paper
• Emerging therapies for chronic hepatitis C virus.

  2008cites this paper
• Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting.

  2008cites this paper
• Emerging Therapies for Hepatitis C and HIV in Drug Abusers

  2008cites this paper
• The way forward in HCV treatment — finding the right path

  2008cites this paper
• Review article: novel therapeutic options for chronic hepatitis C

  2008cites this paper
• Novel hepatitis C drugs in current trials.

  2008cites this paper
• The way forward in HCV treatment — finding the right path

  2008cites this paper
• The “C” of Viral Hepatitis in Children

  2007cites this paper
• Current and future hepatitis C therapies.

  2007cites this paper
• Customizing treatment to patient populations

  2007cites this paper
• Strategies for Managing Anemia in Hepatitis C Patients Undergoing Antiviral Therapy

  2007cites this paper
• New drugs for hepatitis C virus

  2007cites this paper
• Emerging strategies for pegylated interferon combination therapy

  2007cites this paper
• Interferon-based therapy of hepatitis C.

  2007cites this paper
• Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.

  2007cites this paper
• Treating hepatitis C in African Americans

  2007cites this paper
• Anemia and clinical outcomes in hepatitis C.

  2007cites this paper
• [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].

  2007cites this paper
• The way forward in HCV treatment — finding the right path

  2007cites this paper
• Lhpatite C en 2007 Des progrs. Peut-on mieux faire

  2007cites this paper
• Iconography : Malades atteints d’hépatite chronique C non répondeurs : définitions de la non-réponse et stratégies thérapeutiques

  2007cites this paper
• New treatments for hepatitis C: Life cycle lessons

  2007cites this paper
• Comment traiter les malades non répondeurs à la bithérapie antivirale C

  2007cites this paper
• Experiences on Antiviral Treatment for Chronic Viral B and C Hepatitis in Hungary (1998–2004). A Nation-Wide Study

  2007cites this paper
• complicationsviral hepatitis C: efficacy, side effects, and

  2007cites this paper
• Small Molecule and Novel Treatments for Chronic Hepatitis C Virus Infection

  2007cites this paper
• Absorption, Metabolism, and Excretion of [14C]Viramidine in Humans

  2006cites this paper
• Recent development of therapeutics for chronic HCV infection.

  2006cites this paper
• Antiviral treatment of hepatitis C

  2006cites this paper
• Present and future therapy for hepatitis C virus

  2006cites this paper
• Nouvelles stratégies thérapeutiques dans l‘hépatite chronique C

  2006cites this paper
• Future Therapies for Hepatitis C

  2005cites this paper